Trials / Completed
CompletedNCT03703544
The Glycaemic Response of Local Foods Using the Continuous Glucose Monitoring System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Singapore Institute of Food and Biotechnology Innovation · Other Government
- Sex
- Male
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study is carried out to determine the effect of high and low GI of local foods using Continuous Glucose Monitoring System (CGMS™) on 24 hour blood glucose profiles.
Detailed description
Glycemic Index (GI) is a method of classifying foods based on the food's ability to raise the blood glucose level. Low GI foods are recommended as Participants will have a lower impact on blood glucose concentrations. The research sets out to determine the effect of GI on 24 hour blood glucose profiles in healthy Chinese male participants. There will be two test sessions where participants will consume either a high or low GI breakfast, lunch, snack and dinner. Participants will take part in two test sessions (each spanning over 3 days and to monitor the participants' glycemic response using a Continuous Glucose Monitoring System (CGMS) throughout the period.This study specifically attempts to see how having high and low GI locally consumed meals impact on blood glucose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High glycemic index | Wheat yellow noodle, glutinous rice, tea with sucrose, biscuits, jelly made with sucrose and teriyaki chicken rice.The foods provided have been tested as high glycemic index. Participants' blood glucose will be monitored using the Continuous Glucose Monitor. |
| OTHER | Low glycemic index | Beta-glucan yellow noodle, basmati rice, tea with isomaltulose, biscuits, jelly made with isomaltulose and mung bean noodles.The foods provided have been tested as low glycemic index.Participants' blood glucose will be monitored using the Continuous Glucose Monitor. |
Timeline
- Start date
- 2017-12-15
- Primary completion
- 2020-05-22
- Completion
- 2020-05-22
- First posted
- 2018-10-12
- Last updated
- 2020-07-17
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT03703544. Inclusion in this directory is not an endorsement.